Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Army Hospital Malpractice Lawsuit Results in $9.5M Settlement Over Botched Gastric Bypass Surgery The medical malpractice lawsuit claims an Army hospital made several errors during gastric bypass surgery, resulting in paralysis and eventual death. January 29, 2024 Katherine McDaniel Add Your Comments The United States government has agreed to pay $9.5 million to the family of a woman who died six weeks after a botched gastric bypass surgery at an Army hospital in Hawaii. The settlement stems from a medical malpractice lawsuit filed by the family of Julie Bond, who suffered fatal complications after weight loss surgery in 2020. According to allegations raised by Bond’s family, staff at Tripler Army Medical Center in Honolulu, Hawaii made several serious surgical errors, which led to further complications that caused her death less than two months later. Bond, a 31-year-old mother and wife to a former Army sergeant, was referred to the hospital’s bariatric surgery program by her primary care physician, after having trouble losing weight she gained during pregnancy earlier that year. The lawsuit indicated Bond underwent a laparoscopic Roux-en-Y gastric bypass procedure at Tripler in November 2020. During the procedure, the stomach is divided to create a new, smaller one, and the small intestine is redirected to the pouch, bypassing the remaining portion of the stomach. Surgical Mistake Led to Paralysis, Death According to the complaint, Bond’s surgeons made a major surgical mistake during the procedure and reattached her small intestine backwards, which caused an intestinal hernia and required an emergency surgery three days later. During the emergency surgery, anesthetists damaged Bond’s lungs, which caused the development of blood clots. She needed a machine to remove the clots but Tripler’s was not working at the time. Instead of transferring her to another facility that had a functioning blood clot-retrieval device and was willing to treat Bond, her doctors decided to prescribe clot-busting medication. Tripler doctors administered tPA, a tissue plasminogen activator protein designed to help the body breakdown blood clots, which then caused Bond to suffer micro-hemorrhages throughout her brain. The bleeding left Bond in a coma for some time, and when she did finally awaken, she suffered from a rare disorder known as locked-in syndrome. Bond was conscious of everything around her when she awoke from the coma, but the syndrome left her completely paralyzed. She could blink and cry but could not breathe, eat, or move on her own. She was completely dependent on a ventilator to breathe and other life support machines to keep her body functioning. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Approximately a month and a half after Bond underwent gastric bypass surgery, she developed sepsis and died on December 16, 2020. To resolve the medical malpractice lawsuit brought against Tripler Army Medical Center, the U.S. government reached a medical malpractice settlement agreement to pay the Bond family $9.5 million. Gastric Bypass Surgery Risks Gastric bypass procedures are often recommended to treat obesity and other metabolic diseases, when diet and exercise have not worked, or when complications from other health conditions prevent weight loss. While the surgeries have been successful in treating obesity, they have been associated with harmful side effects and long-term health complications. Prior research has linked gastric bypass surgery to increased risks of diarrhea, nutritional deficiencies, and other stomach problems. Another study found the surgeries were associated with more health complications, longer hospitalizations, and many needed another surgery or alternative weight loss treatment. Studies have also shown those who underwent gastric bypass surgery faced higher risks of death and venous thrombosis. A recent study found the weight loss procedures may also increase the risk of drug addiction among patients. The findings of that study found gastric bypass surgery recipients faced higher risks of developing non-alcohol substance use disorder (SUD), or addictions to hypnotic, sedative, anti-anxiety, stimulant, and opioid medications. Tags: Army, Blood Clots, Gastric Bypass, Hospital, Medical Malpractice, Paralysis, Surgical Errors, Weight Loss Surgery, Wrongful Death Image Credit: | Find Out If You Qualify for Ozempic or Wegovy Compensation More Ozempic, Wegovy and Mounjaro Lawsuit Stories Ozempic Vision Risks Could Also Include Age-Related Macular Degeneration: Study June 23, 2025 Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court June 18, 2025 Saxenda, Wegovy Vision Loss Lawsuit Filed Over NAION Diagnosis June 13, 2025 1 Comments Jerry January 31, 2024 Whom may I contact about a claim for a “Landmark Decision”? Thank you. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)